Lee-Lean Shu
Chairman, President and Chief Executive Officer
Replay available
GSI Technology (NASDAQ:GSIT) Q4 2020 earnings call, held 2020-05-07. Watch the replay and read the transcript on 6ix.

On 6ix: 6ix.com/event/gsi-technology-inc-gsit-q4-2020-earnings-call
Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.
0:00 Ladies and gentlemen, thank you for standing by. Welcome to the GSI Technologies fourth quarter and fiscal year 2020 results conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session. At that time, we will provide instructions for those who are interested in entering the queue for Q&A. Before we begin today's call, the company has requested that I read the following Safe Harbors statement. The matters discussed in this conference call may include forward-looking statements regarding future events and the future performance of GSI technology that involves risks and uncertainties that could cause actual results to differ materially from those anticipated.
0:56 These risks and uncertainties are described in the company's forms 10Q and 10K, followed with the Securities and Exchange Commission. Many of these risks are currently amplified by and will continue to be amplified by, or in the future may be amplified by, the COVID-19 global pandemic. Additionally, I have also been asked to advise you But this conference call is being recorded today, May 7, 2020, at the request of GSI Technology. Hosting the call today is Lee-Lean Shu, the company's Chairman, President, and Chief Executive Officer. With him are Douglas Schirle and Didier Lasserre, Vice President of Sales. I would now like to turn the conference over to Mr. Xu. Please go ahead, sir.
2:01 Good afternoon and thank you for joining the call. Today we will explain the status of our business in the current environment, provide an update on our APU products, and report on our fourth quarter and full year fiscal 2020 financial results. Despite the uncertainty created by the COVID-19 global pandemic, we remain focused on our long-term strategy. The COVID-19 global pandemic has created unique circumstances for all our stakeholders, and we have instituted many preventive measures and are regularly evaluating those measures and others as we continue to better understand the environment that we are and will be operating in.
2:58 We are confident in GSR Technologies' ability to succeed in these difficult times given our strong financial position. Our team's tremendous experience and knowledge in our legacy business that provides funding for our new product line. On March 31, 2020, we had over $70 million in cash, cash equivalent and short-term and long-term investment. We slowed down. Outside of Taiwan, there were, where there are low shelter-at-home orders in place, the majority of our employees around the world are working from home.
3:46 Our productivity has remained high. and we are moving forward of achieving our product milestones. I am grateful for all of our employees' commitment to delivering excellence in product, service and support during this challenging time. In the fourth quarter, we completed the benchmarking of our initial AP product, Gemini One. In early April, we published The benchmark result was Gemini One in a billion-scale similarity search using the server containing four Gemini APU boards, running at a rate of 400 MHz.
4:32 The results showed that Gemini One performed extremely fast, accurate search on large data sets with a smaller footprint and lower power consumption for a much lower total cost of ownership. Humanized high performance in speed and accuracy with lower total cost ownership is a significant distinction in today's search solution. Real-time search of large databases is increasingly a critical function that is transforming business, scientific, and governmental process. The ability to replace more expensive solutions and provide better performance et al. were able to end the new market with Gemini One.
5:27 There are many differentiators in the Gemini One architecture that creates this enhanced performance. The primary differentiator is the memory-centric design that removes the limitation of serial processing. The Gemini APU trained the database into the memory that is also served as processors. This configuration shows the system to use fewer CPUs and GPUs and compressed computation speeds from tens of minutes to seconds, even microseconds, in numerous critical search applications. Another key differentiator is the number of ALUs or arithmetic and a large GPU unit on a Gemini chip.
6:20 A GPU typically has thousands of AAUs, and a CPU has about a dozen. Gemini One has two million AAUs, allowing the APU to break down the query into a much more granular search. Loss of internal memory and the database load into the APU reduce search time and use less power to perform the to perform the computation. Scalability is another critical differentiator of the Gemini ATU. For large databases that cannot fit in one ATU chip, we can integrate multiple boards with many chips into the server.
7:05 We can build servers with multiple Gemini boards to scale with the size of the database by retaining our performance and keeping power consumption low. Gemini L1 memory loaded with the entire database allows for extremely fast processing time. In some such applications, kernel solutions require a large number of expensive GPUs and CPUs to deliver performance at scale. The search market is growing, and these new solutions, such as the Gemini APU, that deliver own performance while keeping the total cost of ownership low. Finally, Gemini can serve the broader search market as a universal hardware solution and address many different specific use cases, same to its flexibility and customizable software.
8:06 Our software library and algorithm can tailor Gemini for unique search applications with a multiple level of custom programming from assembly code and Arthur Tenzerfeld. There are many different applications for search. We will continue to develop our solutions to address more of these applications over time. Despite the unique current circumstances for all of our stakeholders caused by the COVID-19 global pandemic, we remain focused on executing the multiple opportunities that are ahead for GSI. Let's last examine about our progress on Gemini One.
8:52 The core business will be variable for the real-time, but our SM products continue to be essential for military and defense, as well as telecommunication and the networking customers. Doug will comment on our first physical code outlook in his prepared schema. Now I will hand the call over to Didier. who will highlight the sales and marketing progress on Gemini One and review our business segment performance. Please go ahead, Didier.
9:24 Thank you, Lee-Lean. I'm pleased to report that we are actively marketing Gemini. Our marketing team has created sales collateral to educate end users on all the unique performance characteristics and capabilities of Gemini One. Outreach is now ongoing for facial recognition and drug discovery. We are preparing to commence engaging with military and government customers for signal classification, object detection, and cryptography. Due to current COVID-19 shelter-in-place and work-from-home restrictions, we are building remote cloud-based workshops. We plan to use these remote workshops for demonstrations of Gemini One's functionality and conduct training with customers on our algorithms and software libraries.
10:13 Let me share a couple of specific examples of Gemini One's performance in two applications we are currently pursuing. I am very excited about Gemini's performance in facial recognition search. Our performance data shows prospective customers that the Gemini One facial recognition search engine can process databases of up to 200 million faces with a single APU board. In these searches, Gemini One is delivering highly accurate results while reducing the query times from many minutes to fractions of a second, all with much lower power consumption and edge processing. Another exciting market we are currently developing is drug discovery. You may recall that in the late 2018, we announced a collaboration with the Wiseman Institute in Israel on cheminformatics research.
11:06 They were an early user of a beta Gemini APU solution. They saw markedly improved productivity with the APU's parallel processing technology with the ability to run multiple molecule queries at speeds that far exceed the CPU search capabilities. Now, researchers at the Wiseman Institute are using newly installed boards containing the Gemini 1 APU. Based on the premise that structurally similar molecules exhibit similar biological activities, scientists are researching for the structurally similar compounds to existing drugs that have been successful in treating diseases and fighting viruses.
11:52 With boards containing Gemini 1, Wiseman Institute researchers perform quicker searches using more queries to their database to find molecules with similar properties to their query molecules. The ultimate goal is to decrease the time needed to go from research into clinical trials. Shifting to our sales breakdown for the fourth quarter of fiscal 2020, sales to Nokia were $2.4 million or 28.3% of net revenues compared to $5.2 million or 41.1% of revenues in the same period a year ago. and 2.6 million or 26.3% of net revenues in the prior quarter.
12:39 Nokia sales have been slower in recent quarters, which we expect to continue through the end of June. The situation is somewhat fluid and a subject to change, but at this time Nokia's preliminary forecast shows an improvement in sales in the second half of calendar 2020. Military and defense sales were 30.9% of fourth quarter shipments compared to 22.1% a year ago and 18.9% in the prior quarter. SigmaQuad continues to be our best performing product category with sales of 44.7% of fourth quarter shipments compared to 57.4% in the fourth quarter of last year and 62% in the preceding third quarter. I'd now like to hand the call over to Doug.
13:29 Please go ahead, Doug. Thank you, Didier. For the fiscal year ended March 31, 2020, we reported net loss of $10.3 million for 45 cents per diluted share, a net revenues of $43.3 million compared to net income of $163,000 for one cent per diluted share, a net revenues of $51.5 million in the fiscal year ended March 31, 2019. Gross margin for fiscal 2020 was 58.5% compared to 61.4% in the prior year. Total operating expenses were $36.1 million in fiscal 2020, an increase of 13.6% from $31.8 million in fiscal 2019. Research and development expenses were $25.2 million compared to $21.4 million in the prior fiscal year and selling general and administrative expenses were $10.9 million compared to $10.5 million in fiscal 2019.
14:33 The increase in research and development expenses was primarily due to the development of the APU, the company's AI processor, including a charge of $2.7 million during the third quarter of fiscal 2020 for purchased intellectual property that is being incorporated into the next generation of Gemini chips. Fiscal 2020 operating loss was $10.8 million compared to an operating loss of $182,000 in the prior year. The increase in operating loss is primarily due to the decrease in revenue and gross profit in higher research and development expenses. Fiscal 2020 net loss included interest and other income of $712,000 and a tax provision of $247,000.
15:21 compared to $450,000 in interest and other income and a tax provision of $105,000 a year ago. The company reported a net loss of $3.8 million, or $0.68 per diluted share, a net revenues of $8.5 million for the fourth quarter of fiscal 2020, compared to a net loss of $102,000, or $0 per diluted share, a net revenues of $12.7 million for the fourth quarter of fiscal 2019, and a net loss of $4.6 million, or 20 cents per diluted share, on net revenues of $10 million for the third quarter fiscal 2020. Gross margin was 52.5% compared to 61.3% in the prior year period and 60.2% in the preceding third quarter.
16:13 The change in gross margin was primarily due to changes in the mix of products sold and the negative impact of manufacturing overhead on reduced revenues. Total operating expenses in the fourth quarter of fiscal 2020 were $8.4 million compared to $8.1 million in the fourth quarter of fiscal 2019 and $10.8 million in the prior quarter. Research and development expenses were $5.6 million compared to $5.6 million in the prior year period and $8.2 million in the prior quarter. The decrease in R&D expenses from the prior quarter reflects a charge of $2.7 million during the third quarter of fiscal 2020 for purchased intellectual property that we are incorporating into the next generation for Gemini chips.
17:01 Building general and administrative expenses were $2.8 million in the quarter to March 31, 2020, compared to $2.6 million in the prior year and $2.6 million in the previous quarter. Fourth quarter fiscal 2020 operating loss was $3.9 million compared to an operating loss of $365,000 in the prior year period and an operating loss of $4.7 million in the prior quarter. Fourth quarter fiscal 2020 net loss included interest and other income of $148,000 and a tax provision of $65,000 compared to $186,000 in interest and other income and a tax benefit of $77,000 for the same period a year ago. In the preceding third quarter, net loss included interest and other income of $207,000 and a tax provision of $84,000. Total fourth quarter pre-tax stock-based compensation expense was $644,000 compared to $580,000 in the comparable quarter a year ago at $629,000 in the prior quarter.
18:01 In March 31, 2020, we had $66.6 million in cash Cash Equivalence and Short-Term Investments, and $4.1 million in Long-Term Investments. Compared to $61.8 million in Cash, Cash Equivalence and Short-Term Investments, and $9 million in Long-Term Investments at March 31, 2019. Working Capital was $70.9 million as of March 31, 2020, versus $68.6 million at March 31, 2019, with no debt.
18:46 Blockholders' Equity as of March 31, 2020, as 89.6 million compared to 93.2 million as of the fiscal year ended March 31, 2019. Fourth quarter results were within the range of guidance provided in our last earnings release for net revenues in the range of 8.5 million to 9.5 million with gross margin of approximately 50% to 52%. Our current expectations for the upcoming quarter are net revenues in the range of 7 million to 8.8 million with gross margin of approximately 48% to 52%. We've expanded our guidance range for the upcoming quarter to reflect the impact of possible changes in customer buying patterns and communication limitations related to shelter-in-place restrictions that require a significant number of our customer contacts to work from home.
19:37 The disruption to the marketplace that we're currently experiencing is like anything we've ever had to deal with. While we continue to monitor the business metrics that we have historically used to predict our financial performance, we are uncertain as to whether these metrics will operate consistently with our historical experience. Operator, at this point, we'll open the call to Q&A. Thank you. If you would like to ask a question, please signal by pressing Star 1 on your telephone keypad. If you are using a speakerphone, Please make sure your mute function is turned off to allow your signal to reach our equipment. Again, that's star one to ask a question. We'll pause for just a moment to allow everyone an opportunity to signal for questions.
20:41 We'll now take our first question from Kurt Calamandernis. Please go ahead. Your line is...
20:50 Hi, guys. Can you hear me?
20:52 Yeah, Kurt, we can hear you.
20:53 Oh, great. Okay. Wiseman, are they getting just some free chips and boards as a collaborator? Are they planning on needing to order any, or how is that kind of going? Are they being your guinea pig to be able to sell to other places?
21:12 Yes to both accounts. So we have loaned them in the past, and we have given them the upgraded, you know, the new system recently, as we mentioned, and they plan on paying for that system.
21:27 Okay. Are they a more modest prospect compared to some other larger drug companies? Because it seems like right now that area is as hot as it's ever going to be. and I'm wondering how you're able to get the word out or get some presentations to some of these drug companies.
21:51 As I mentioned in the discussion earlier, we have the marketing collateral that we've recently put together within the last month. And it consists of a sales brief, which is a one-page front and back High Level Explanation, and we've broken it down by market segments. So we have one currently for facial recognition, and we have one for the drug discovery. And we put that out to the world. And as a backup, we have more in-depth presentations and more in-depth technical write-ups, almost like white papers, along with a presentation for each of these market segments. And so we've been doing some of the demos and some of the presentations based off of the initial outreach with the one-page sales brief.
22:48 How are you feeling early on about those conversations or presentations?
22:54 Good. I mean, certainly if you've seen some of the results that we put out from the benchmarking, everything looks really good. I mean, we're certainly early in the process. As I mentioned, we just received these documents within the last few weeks. So it's early in the process, but certainly the results are what we expected, and so we're communicating that to the marketplace now. So, I mean, so far it's been good feedback.
23:21 Okay. And facial recognition, I would agree the results of what you're doing are extremely impressive. So I'm trying to game out how we might start getting some The facial recognition looks extremely positive. Do you have some type of a partner there, and then how is that sales process? Have some of them already been aware, or are you starting from scratch? How is that looking?
23:49 So we have two partners, which we still have one. One of them was having some financial difficulties, but the other one is still there. They're We're doing a POC with them right now based off of their algorithms, and so that's going to take some time. And then beyond them, besides beyond the initial partners, we're now, as I mentioned, reaching out to other folks in this space to be able to give them presentations and then more detailed white papers.
24:24 Is government part of that?
24:26 Government is part of that, yes.
24:31 One other thing, and then I'll let somebody else in, but either Doug or probably Doug, I get questions, you know, oh, I saw so-and-so selling the stock, and I try to explain, you guys get paid in options, they come due, and many times you're selling some stock to cover the taxes or whatever. Can you just explain, because sometimes it almost seems like an overhang, people are like, why would they be selling the stock if things are looking so good? But explain a little bit about, you know, the options I think are part of your compensation and then what the mechanics. I think most of the time there's really not net selling. It's generally even or acquiring, but just put some color because that seems to be confusing.
25:16 Yeah, so every employee at GSI Technology receives an option grant when they're hired. And those typically vest over a four-year period, 25% per year. It's not monthly, it's annually. and that's true for executive officers. Subsequent to that, every year we have evergreen grants and everyone gets an evergreen grant on the anniversary or in the quarter just after the anniversary of their hire date. So those would vest over four years for employees and officers, when they get theirs, they vest four years into the future. It's not a four year vest, it's a 100% cliff vest after four years. and all of these options have a 10-year life on them.
26:01 And there are a number of people with options that are expiring, I think around May 10th, Saturday, Saturday of this week, and there are a lot more expiring in August. And a lot of times when you see officers selling shares, in many cases they sell shares and use the net proceeds of those sales to buy additional shares. From an officer perspective, most of the officers are acquiring shares, increasing their position in the company, not decreasing. We've also had some directors who also get option grants. They've also, over time, been acquiring some shares. So when you see people selling, it's really not because they want to sell.
26:46 It's because they don't have a choice. They need the money to buy additional shares, which they've typically been using those proceeds to buy additional shares on other grants.
26:56 Great. I just needed to have that clarified, I think, just generally speaking, so I appreciate that. I'll step out, and if I have something, come back in. Thank you. Thank you. Again, if you would like to ask a question, it's Star 1 on your telephone keypad. We have no further questions in the Q&A. Apologies. There is a follow-up question from Kurt. Please go ahead. Your line is...
27:39 Sorry, thanks. I know today is crazy. There's multiple calls, so sometimes there's only one or two on a call, but I wanted to give somebody a chance if need be. Any update on Ranhard? Just anything for the good of the order on getting heritage or any outlook out there?
27:58 So we finished the qualification, so we are now on the 288 megabit SQ2 Plus family, which is the lead family we started with. We have finished qualification, so we now have, and not only did we finish our internal qualification, but our partner finished their V certification, so their QMLV certified now. So we are now able to offer QMLV equivalent devices. So we've read all the data sheets. Now, we're still obviously going through, like you said, we're getting the heritage and going after some of the folks. So it's not clear whether our first orders will be RAD hard or RAD tolerant because we do have some nice wins in the RAD tolerant. We're just waiting for the funding and the orders to come from that.
28:54 As far as, you know, we were talking about in the past about hardening also our SIG Burst MBT family along with APU. APU, as we've discussed in the past, we've done some preliminary testing back in November, and the results were very promising. We were hoping to get back into the facility to do more bean time testing, actually in April, but obviously with everything going on with the COVID-19, that's on hold right now. So adding new families right now is on hold until we can get back into the facility. But at this point, the parts that are qualified and we do have testing on that we're continuing to promote, it's just a matter of the timing of the funding and when those will come to fruition.
29:44 Okay, great. And you did some training on APU in, was it January, before all this stuff hit? Yes.
29:51 It was last November.
29:53 Oh, I thought you didn't have anything at the office in your training facility there this year. I was thinking something was in January. With the people that you've contacted before, do you see any chance of indications of interest, some type of orders through the summer? Is it too hard to tell? What's kind of your gut on that?
30:15 You know, it's too difficult to predict. And I'll tell you what, I was having a conversation some time back when Somebody asked me, so when do you expect an order on that, because I was talking about a rad tolerant opportunity. And I said, I expect the order to last third quarter, because that's when it was supposed to come in. And so for me to make a prediction...
30:35 I'm sorry, I'm on APU. I apologize. I switched gears. On APU, I meant on APU, I thought, yeah, sorry about that. So I thought you had a training for APU in January at their headquarters or some kind of training thing. So my question is more about APU. Do you see getting any indication of interest or possible POs of some sort this summer as some of these people have maybe been tracking along the way? Or what's kind of your feeling about that? I apologize, I meant APU, not Randolph.
31:08 I'm sorry, yeah. So the APU, that is correct. The training was done in the first quarter. It was, I can't remember if it was in January or beginning of February. But you're correct. We went out and did the training, and it happened to be for a government entity who actually purchased a board from us back in December. And so those conversations are still occurring. We've also done something additional for the APU in that market space. We've become a member of something called SHREC, S-H-R-E-C. and so we're part of that member. And so what we have is we have some active PhDs and also other people within the Shrek organization or, actually it's not organization, but group that will be doing some work with us on adding additional resources for the APU, specifically in areas where they can write additional libraries or algorithms or they can make changes to the FPGA that is currently on our APU board to be able to utilize more of the resources within the FPGA that's on the board.
32:24 And so that's happening now, and those are all geared towards the military government type of applications. So that's a recent within the last quarter update.
32:39 Well, do you think this summer it's possible to get some Initial Orders, or how are you thinking about that?
32:47 Hard to predict, Kurt. I mean, I could say that yes, and then it doesn't happen. It's just really hard to predict when it's going to happen. But certainly, as we mentioned in the conversation at the beginning, between signal classification, between object detection, cryptography, there's a massive amount of interest for this type of a technology in that government space.
33:13 So you were talking about the price of these. So at the price you were thinking of the APU boards, It still would be cost-effective when you're looking at speed, power, performance, footprint, or would you have to have a lower price than what you're originally thinking?
33:54 No. There's no reason for us to have any lower prices on any of our initial assessments. Okay.
34:02 Great, guys. It's been a long road, and now we've got a pandemic, so we'll have to work through that and I look forward to how this all pans out. Thanks a lot.
34:15 Thank you. Thank you, Kurt. There are no further questions in the queue at this time.
34:29 Thank you all for joining us. We look forward to speaking with you again when we report our first quarter, physical 2021. Thank you. Ladies and gentlemen, this concludes today's conference. Thank you for your participation in this discussion.
Follow GSI Technology, Inc. into a list and get an email when it puts out news.
Chairman, President and Chief Executive Officer
Chief Financial Officer
Investor
Vice President of Sales